PD-1 inhibitors in NSCLC: A case discussion

 LECTURE   09/2020

Watch also the other lectures

 

1. Welcome and Introduction
Tony Mok

 

2. PD1 inhibitors for NSCLC: Where are we now?
Tony Mok

 

3. One molecule, many mechanisms of action: Why all PD1 inhibitors are not the same
Raffaele Califano

 

4. How will the new wave of PD1 inhibitors change the treatment landscape in NSCLC?
Anne-Marie C. Dingemans

 

6. PD1 inhibitors for NSCLC: Future challenges, future potential
Giorgio Scagliotti

 

7. Exploring the promise of emerging PD1 inhibitors in NSCLC
Giorgio Scagliotti

Rating

Rate this resource

Nice to see you!

For newest details on our EHA materials in a personal video meeting, please click here!
Service